Brief: ALX Oncology Reports Fourth Quarter And Full Year 2022 Financial Results

ALX Oncology Holdings

09/03/2023 21:19

March 9 (Reuters) - ALX Oncology Holdings Inc  ALXO.O :
    * ALX ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL
HIGHLIGHTS AND UPCOMING MILESTONES
    * ALX ONCOLOGY HOLDINGS INC - QTRLY NET LOSS PER SHARE,
BASIC AND
DILUTED $0.75
    * ALX ONCOLOGY - BELIEVES CASH & CASH EQUIVALENTS,
INVESTMENTS AND
ABILITY TO DRAW DOWN OPTIONS ARE SUFFICIENT TO FUND PLANNED
OPERATIONS THROUGH MID-2025

Source text for Eikon:  ID:nGNX12QVtC 
Further company coverage:  ALXO.O 

 ((Reuters.Briefs@thomsonreuters.com;))